Drug Information Cost Analysis 24-6-2012

7/30/2019 Drug Information Cost Analysis 24-6-2012

1/87

No Date Questioner Name Nat Sex Type of

Questioner

Qualification Work

Address/De

pt

Pt's Name ID

1-Oct-12 Dr.Hafiz NA M Physician Consultant KSMC NA NA

5-Oct-12 Dr.Omar NA M physician Resident KSMC NA NA

8-Oct-12 Dr.Nanamiya Bangladeshi M Physician Na KSMC NA NA

8-Oct-12 Dr.Safer Almurai NA M Physician Resident KSMC NA 397420

10-Oct-12 Dr.Nanamiya Bangladeshi M Physician Consultant KSMC NA 469552

13-Oct-12 Dr.Nanamiya Bangladeshi M Physician Consultant KSMC NA NA

13-Oct-12 Dr.Haitham Saudi M Physician Consultant KSMC NA NA

15-Oct-12 Dr.Mohammad NA M Physician Resident KSMC NA NA

16-Oct-12 Dr.Sammy Sudanese M Physician Resident KSMC NA 601061

16-Oct-12 Dr.Obeid Saudi M Physician Specialist KSMC NA NA

16-Oct-12 Dr.Sohail NA F Physician Resident KSMC NA NA

17-Oct-12 Sis.Nancy Indian F Nurse NA KSMC NA NA

20-Oct-12 Dr.Hafiz NA M Physician Consultant KSMC NA NA

20-Oct-12 Dr.Hafez NA M Physician Consultant KSMC NA NA

31-Oct-12 Sis.Bincy Indian F Nurse NA KSMC NA 433539

3-Nov-12 Dr.Safar NA M physician NA KSMC NA NA

4-Nov-12 Dr.Abdullah NA M Physician Na KSMC NA NA

10-Nov-12 Dr.Hafiz NA M Physician Consultant KSMC NA NA

11-Nov-12 Dr.Nawal Al-Harbi NA F Physician NA KSMC NA NA

11-Nov-12 Dr.Aseera NA F Pharmacist NA DPIC NA NA

11-Nov-12 Dr.Sabar Hussain NA M physician NA KSMC NA NA

14-Nov-12 Dr.Farida NA F Physician Consultant KSMC NA NA


2/87

17-Nov-12 Dr. Reem Egyptian F Pharmacist NA NA NA NA

19-Nov-12 Khalid Otaibi Saudi M Physician Others NA NA NA

20-Nov-12 Dr. Abdullah Al-

Majed

Saudi M Physician Consultant KSMC NA NA

20-Nov-12 Dr.Saleh Al-Sehr Saudi M physician Consultant KSMC NA NA

21-Nov-12 Dr.Manah Egyptian F Physician NA KSMC NA NA

24-Nov-12 Dr.Abdulrahman Saudi M Physician NA KSMC NA NA

1-Dec-12 Hamed NA M Other NA KSMC NA NA

3-Dec-12 Dr. Tarek Saudi M Physician Consultant KSMC NA NA

10-Dec-12 Dr.Hafez NA M Physician Consultant KSMC NA NA

11-Dec-12 Dr.Kamal NA M Physician Senior

Registrar

KSMC NA NA

12-Dec-12 Dr.Abdulrahman Al-

Sehri

Saudi M Physician Consultant KSMC NA NA

17-Dec-12 Dr.Salaha NA F physician Registrar KSMC NA NA

22-Dec-12 Dr.Amir Saudi M Physician Registrar T1B3 NA NA

12-Dec-12 Ahmad Saudi M NA NA KSMC NA NA

20-Dec-12 Dr.Radwan NS M Physician Consultant KSMC NA NA

24-Dec-12 Dr.Ayman Saudi M Physician NA KSMC NA NA

25-Dec-12 Hana NA F Pharmacist NA Pharmacy NA NA

30-Dec-12 Dr.Abdulmajed NA M Physician Consultant KSMC NA NA


3/87

Nat Sex Wt Diagnosis Ward Type of Question Question Answer

NA NA NA NA NA Others Is the action of clopidogrel

reversable or irreversable?

Answer given

NA NA NA NA NA Pharmacokinetic How to calculate GFR? Answer given

NA NA NA NA NA Drug Availability Availability of tazocin Answer given

NA M NA NA NA Dosage

Administration

Dose of warfarin to

achieve therapeutic INR

level

Answer given

NA F NA NA T1A4 Drug Availability Availability of albumin Answer given

NA F NA NA NA General

Information

N.acetylcysteine dose in

pulmonary disease and its

availabilit

Answer given

NA F NA NA NA General

Information

Use of N.acetylcysteine Answer given

NA NA NA NA NA Drug-Drug

Interaction

Is there drug drug

interaction between

warfarin and

henobarbital?

Answer given

NA M NA NA T1A3 Drug Interactions Drug drug interaction of

captopril anf kcl

Answer given

NA NA NA NA NA Drug availability Availability of meropenem Same day

NA NA NA NA NA General

Information

Drug causing properam Answer given

NA NA NA NA NA Drug Availability Availability of levedopa Answer given

NA NA NA NA NA Others Duration of clexane in ACS

pt?

During the hospitalization

period.

NA NA NA NA NA Others Wich is better ACSatrovastin or simvastatin

Answer given

NA NA NA NA NA Dosage/Administra

tion

How to dilute vigra? Answer given

NA NA NA NA NA Drug Availability warfarin availability in how

much concentration

1-3 mg in our hospital.

NA NA NA NA NA Drug Availability Availability of rabbies

vaccine

Same day

NA NA NA NA NA Others Does the benefits of using

warfarin,aspirin,and

clopidogrel outweighs the

risk?

Answer given

NA NA NA NA NA Adverse Drug

Reaction

Docusta sodium used in

pregnancy ?

Answer given

NA NA NA NA NA Dosage/Administra

tion

Wich antibiotic consider

during fistula surgery?

Answer given

NA NA NA NA NA Therapeutic Use Cotrimoxazole dose? Answer given

NA NA NA NA NA Others Can we put manitol in

boiling water to remove

cr stals?

Answer given


4/87

NA NA NA NA NA Pharmacokinetic Neonate start on

vancomycin fot catheter

related to infection MRSA

in blood low level,what

shall we do?

Answer given

NA NA NA NA NA Others Is cigarette is

carcinogenic?

Answer given

NA NA NA NA NA Poisoning Pt.is having

spastisity,unresponsiveness,dialated pupils,non

reactive and respiratory

distress what medications

can do this?

Narcotics

NA NA NA NA NA Pharmacokinetic Pharmacokinetic of

morphine

Answer given

NA NA NA NA NA Poisoning How to manage cosmetic

poisoning in pediatric

atient

Answer given


Reaction

Medication that may cause

thrombocytopnea

Answer given

NA NA NA NA NA Poisoning Pt. took 2 tabs of thyroxine

dose 200 mg,she is ok no

sign and symptoms shall I

take her to ER?

No need to bring her in

ER,no sign and

symptoms,its not a toxic

dose

NA NA NA NA NA Dose

Standardization

The usual dose of

clindamycin?

Answer given

NA NA NA NA NA Others What is the drug of choice

in heart block?

Answer given

NA NA NA NA NA Others Can be used

spironolactone in

combination with ACE'I

and lasix

Answer given


Reaction

What is the adverse drug

reaction of octreoticide on

blood?

Answer given

NA NA NA NA NA Drug Availability Other drug for vertigo Answer given

NA NA NA NA NA Drug Administation Can we give heparin 5000

IU as SQ?

Yes

NA NA NA NA NA Drug-Drug

Interaction

Drug drug interaction of

zestril,warfarin,amlor,lasix,

atenolol,and ke ra

No major drug drug

interaction

NA NA NA NA NA Drug coverage does tazocin covers

anerobes?

Yes

NA NA NA NA NA Drug Identification Mechanism of action of

octreokide in chylothorax

Answer given

NA NA NA NA NA Pharmacokinetic Can chronovalporate be

iven 12 hrs?

Yes it can

NA NA NA NA NA Dosage Coverage Is Fluconazole is the drug

of choice for candidia?

Answer given


5/87

Total Cost

Saving ($)

MI Data

Bank

Documente

d

Question

Was

Answered

Level Description Cost 95% Cl Total Cost impact

of DPIC Inquiries

No Yes NA NA NA NA NA







No Yes 3a Additional Tests 95.00 73-116 NA





No Yes V NA NA NA NA



NA NA NA NA NA NA NA








6/87

No Yes 3a;4b additional tests;additional

treatment /non invasive

procedure

95;411.00 73-116;267-

554

NA




NA Yes NA NA NA NA NA








No Yes 1 No change in therapy or

no harm

0.00 NA NA







7/87

Severity

Rating

Physician

Visit

Additional

Tests

Additional

Treatment

Noninvasiv

e

Procedure

Invasive

Procedure

Increased

LOS

ICU

Transfer

LTC

Admission

NA NA NA NA NA NA NA NA NA







NA NA NA
















8/87




















9/87

Death Total Sensitivity

Analysis

Notes Pharmacist

Reporting

NA NA NA NA Amal Al-

Aqqad


A adNA NA NA NA Dr.Moin

Khaja

NA NA NA NA Dr.Moin

Khaja

NA NA NA NA Dr.Moin

Kha a

NA NA NA NA Dr.Moin

Khaja

NA NA NA NA Dr.Moin

Khaja

NA NA NA Dina Fouda

NA NA NA NA Dr.Moin

Khaja

NA NA NA NA Dr.Moin

Khaja

NA NA NA NA Dr.Moin

Khaja

NA NA NA NA Dr.Moin

Kha a


Aqqad

NA NA NA NA Amal Al-A ad

NA NA NA NA Dr.Moin

Khaja

NA NA NA NA Dr.Moin

Khaja

NA NA NA NA Dr.Moin

Khaja


Aqqad

NA NA NA NA Dr.Moin

Khaja

NA NA NA NA Dr.Moin

Khaja

NA NA NA NA Dr.Moin

Khaja


Aqqad


10/87

NA NA NA NA Aseera Al-

Sarhan

NA NA NA NA Aseera Al-

Sarhan


Aqqad

NA NA NA NA Suzan

Asfour


Aqqad

NA NA NA NA Suzan

Asfour


Aqqad

NA NA NA NA Suzan

Asfour


Aqqad


Aqqad

NA NA NA NA Suzan

Asfour

NA NA NA NA Dr.Moin

Kha a

NA 0 NA NA Dina Fouda


Aqqad

NA NA NA NA Suzan

Asfour

NA NA NA NA Suzan

Asfour


A ad

NA NA NA NA Sara Salem


11/87


12/87


13/87


14/87


15/87

Month No. of Question PercentageType of

QuestionNo. Percentage

January 15 100% Poisoning 7 46.7%

Total 15 100%Drug

Identification3 20.0%

Drug Availability 2 13.3%

Type of

QuestionerNo. Percentage

Dosage

Administration1 6.7%

Physician 12 80%Dose

Standardization1 6.7%

Dentist 1 6.7%General

Information 1 6.7%

Intern 1 6.7% Total 15 100%

Nurse 1 6.7%

Total 15 100% MonthTotal Cost

Saving ($)

January 701080.00

Qualification

of QuestionerNo. Percentage Total 701080.00

Consultant 6 40%

NA 4 27%

Senior

Registrar 2 13%

Registrar 2 13%

Intern 1 7%

Total 15 100%

Work Address No. Percentage


16/87

Pediatric

Hospital7 47%

NA 4 27%

General

Hospital3 20%

Dental

Hospital

1 7%

Total 15 100%

0

2

4

6

8

10

12

14

16

No. of Question Percentage

15

100%

DPIC QUESTION

JANUARY 2012

7

3

21

TYPE OF QUES


17/87

Reporting

PharmacistNo. of Question

Total Cost

($)

Reporting

Pharmacist

Type of


Yousef Al-Omi 6 600000.00Yousef Al-

OmiPoisoning 6 100%

Hajer Al-

Mudaiheem3 100129.00 Total 6 100%

Khaja Moinuddin 2 951.00

Joza Al-Otaibi 2 0.00Reporting

Pharmacist

Type of


Dina Fouda 1 0.00Hajer Al-

Mudaiheem

Dosage

Administr

ation

1 33.3%

Nora Al-Juhani 1 0.00 Poisoning 1 33.3%

Total 15 701080.00

Dose

Standardi

zation

1 33.3%

Total 3 100%

Reporting

PharmacistNo. of Question Percentage

Yousef Al-Omi 6 40%

Hajer Al-

Mudaiheem3 20%

Khaja Moinuddin 2 13.3%

Joza Al-Otaibi 2 13.3%

Dina Fouda 1 6.7%

Nora Al-Juhani 1 6.7%

Total 15 100%


18/87

0

2

4

68

10

12

14

16

1 1

15

ION

0

2

4

6

8

1012

14

16

Physician Dentist Intern Nurse Total

12

1 1 1

15

TYPE OF QUESTIONER


19/87

Reporting

Pharmacist

Type of


Severity

RatingNo. Percentage

Khaja

Moinuddin

General

Information1 50% 1 4 23.5%

Drug

Availability1 50% 2 4 23.5%

Total 2 100% 4b 2 11.8%

6 7 41.2%

Reporting

Pharmacist

Type of

QuestionNo. Percentage Total 17 100%

Joza Al-

Otaibi

Drug

Identification

2 100%

Total 2 100%

Reporting

Pharmacist

Type of


Dina Fouda

Drug

Identificatio

n

1 100%

Total 1 100%

Reporting

Pharmacist

Type of


Nora Al-

Juhani

Drug

Availability 1 100%

Total 1 100%


20/87


21/87



February 29 100% Poisoning 10 33.3%

Total 29 100%General

Information7 23.3%

Drug


Type of


Dosage


Physician 26 89.7%Dose


Intern 2 6.9% Therapeutic Use 2 6.7%

Clinical

Pharmacist1 3.4%

Drug-Drug

Interaction1 3.3%

Total 29 100% Drug Availability 1 3.3%

Total 30 100%

Qualificationof Questioner

No. Percentage

Resident 12 41.4%

Registrar 8 27.6%

Consultant 5 17.2%

Intern 2 6.9% Month

Total Cost

Saving ($)

Senior

Registrar1 3.4% February 1006772.5

Clinical

Pharmacist1 3.4% Total 1006772.5

Total 29 100%


22/87


Pediatric

Hospital9 31%

NA 9 31%

General

Hospital11 37.9%

Total 29 100%

0

5

10

15

20

25

30


29

10

DPIC QUESTION

FEBRUARY 2012


23/87

Reporting


Total Cost

($)

Reporting

Pharmacist

Type of

QuestionNo.

Yousef Al-Omi 9 900000.00Yousef Al-

OmiPoisoning 9

Khaja Moinuddin 9 6189.50 Total 9

Hajer Al-

Mudaiheem5 583.00

Joza Al-Otaibi 2 0.00Reporting

Pharmacist

Type of

QuestionNo.

Dina Fouda 2 0.00Hajer Al-

Mudaiheem

Dosage

Administratio

n

2

Nora Al-Juhani 2 100000.00Drug-Drug

Interaction1

Total 29 1006772.50Drug

Identification1

Dose

Standardizati

on

1

Reporting

PharmacistNo. of Question Percentage Total 5

Yousef Al-Omi 9 31%


Hajer Al-

Mudaiheem5 17.2%

Joza Al-Otaibi 2 6.9%

Dina Fouda 2 6.9%


Total 29 100%


24/87

%

0

5

10

15

20

25

30

Physician Intern ClinicalPharmacist

Total

26

2 1

29

TYPE OF QUESTIONER


25/87

PercentageReporting

Pharmacist

Type of


Severity

RatingNo.

100%Khaja

Moinuddin

General

Information7 70% 1 6

100%Dosage

Administratio

n

1 10% 2 11

Drug

Availability1 10% 4a 3

PercentageTherapeutic

Use1 10% 4b 7

40.0% Total 10 100% 4c 1

20.0% 6 10

20.0% Total 38

20.0%

100%

ReportingPharmacist

Type ofQuestion

No. Percentage

Joza Al-

Otaibi

Drug

Identification1 50%

Dose

Standardizatio

n

1 50%

Total 2 100%

Reporting

Pharmacist

Type of


Dina FoudaDrug

Identification1 50%

Therapeutic

Use1 50%


26/87

Total 2 100%

Reporting

Pharmacist

Type of


Nora Al-

Juhani

Poisoning 1 50%

Drug

Identification1 50%

Total 2 100%

0

10

20

30

10

7

43

2 2 1 1

30

TYPE OF QUESTION


27/87

Percentage

15.8%

28.9%

7.9%

18.4%

2.6%

26.3%

100%


28/87



March 25 100% Poisoning 10 38.5%

Total 25 100%

Drug

Availability/For

mulary

7 26.9%

Dose


Type of

QuestionerNo. Percentage Therapeutic Use 2 7.7%

Physician 22 88.0%Drug

Administration

1 3.8%

Pharmacist 2 8.0% Total 26 100%

GS 1 4.0%

Total 25 100%

Qualification

of Questioner No. Percentage

Registrar 6 24.0%

Resident 4 16.0%

Consultant 13 52.0%

Senior

Registrar2 8.0% Month

Total Cost

Saving ($)

Total 25 100% March 1001792

Total 1001792


General

Hospital23 92.0%

25

25

DPIC QUE

MARCH


29/87

Pediatric

Hospital1 4.0%

MOH 1 4.0%

Total 25 100%

0

5

10

15

20

No. of Question


30/87

Reporting


Total Cost

($)

Reporting

Pharmacist

Type of

Question

Yousef Al-Omi 10 1000000.00Aseera Al-

Sarhan

Dose

Standardizati

on

Hajer Al-

Mudaiheem8 614 Total

Khaja Moinuddin 5 951

Aseera Al-Sarhan 1 0Reporting

Pharmacist

Type of

Question

Rawan Zmeili 1 227

Dose

Standardizati

on

Total 25 1001792.00Hajer Al-

Mudaiheem

Drug

Availability/F

ormulary

Total

Reporting


Yousef Al-Omi 10 40.0%

Hajer Al-

Mudaiheem8 32.0%


Aseera Al-Sarhan 1 4.0%

Rawan Zmeili 1 4.0%

Total 25 100%

STION

012

20

2522

TYPE OF QUESTIONER


31/87

Percentage

100%

0

5

10

Physician Pharmacist GS

21


32/87

No. PercentageReporting

Pharmacist

Type of


Severity

Rating

1 100%Khaja

Moinuddin

Drug

Availability/

Formulary

4 80% 1

1 100%

Drug

Administrati

on

1 20% 2

Total 5 100% 6

No. Percentage 4a

5 62.5%Reporting

Pharmacist

Type of

Question

No. Percentage 4b

3 37.5%Rawan

Zmeili

Therapeutic

Use1 100% Total

8 100% Total 1 100%

Reporting

Pharmacist

Type of


Yousef Al-

Omi Poisoning 10 100%

Total 10 100%

25

20

30

10

7 6

26

TYPE OF QUESTION


33/87

Total

0

2 1


34/87

No. Percentage

5 18.5%

8 29.6%

10 37.0%

2 7.4%

2 7.4%

27 100%


35/87


36/87



April 20 100% Poisoning 11 52.4%

Total 20 100%

Drug

Availability/For

mulary

3 14.3%

Dose


Type of


Drug


Physician 17 85.0% Compatibility 1 4.8%

Nurse 3 15.0% Total 21 100%

Total 20 100%

Qualification

of QuestionerNo. Percentage

Registrar 4 20.0%

Resident 3 15.0%

Staff Nurse 3 15.0%

Consultant 10 50.0% Month

Total Cost

Saving ($)Total 20 100% April 1100604.50

Total 1100604.50

Work Address No. Percentage20

DPIC QUESTION

APRIL 2012


37/87

General

Hospital10 50%

Pediatric

Hospital10 50%

Total 20 100%

0

5

10

15

20

No. of Question Perc

0

10

20

30


38/87

Reporting


Total Cost

($)

Reporting

Pharmacist

Type of

Question

Yousef Al-Omi 10 1000000.00 Dina Fouda

Dose

Standardizati

on

Hajer Al-

Mudaiheem4 129.00

Drug

Administratio

n

Khaja Moinuddin 3 475.50 Total

Nora Al-Juhani 2 100000.00

Dina Fouda 1 0 ReportingPharmacist

Type ofQuestion

Total 20 1100604.50

Dose

Standardizati

on

Hajer Al-

Mudaiheem

Drug

Administratio

n

Compatibility

ReportingPharmacist

No. of Question Percentage Total

Yousef Al-Omi 10 50.0%

Hajer Al-

Mudaiheem4 20.0%



Dina Fouda 1 5.0%Total 20 100.0%

20 17

20

TYPE OF QUESTIONER


39/87

entage

100%

0

5

10

15

Physician Nurse Total

3

11

3 4 2 1

21

TYPE OF QUESTION


40/87


Pharmacist

Type of


Severity

Rating

1 50%Khaja

Moinuddin

Drug

Availability/

Formulary

3 100% 1

1 50% Total 3 100% 2

2 100% 4b

6

No. Percentage ReportingPharmacist

Type ofQuestion

No. Percentage Total

2 50%Nora Al-

Juhani

Dose

Standardizat

ion

1 50%

1 25% Poisoning 1 50%

1 25% Total 2 100%

4 100%

Reporting

Pharmacist

Type of


Yousef Al-

OmiPoisoning 10 100%

Total 10 100%


41/87


42/87

No. Percentage

6 28.6%

3 14.3%

1 4.8%

11 52.4%

21 100%


43/87



May 21 100% Poisoning 9 42.9%

Total 21 100%Dose


Therapeutic Use 2 9.5%

Type of


General

Information2 9.5%

Physician 19 90.5% Pharmacokinetic 1 4.8%

Nurse 1 4.8%Drug


Pharmacist 1 4.8%Drug


Total 21 100%Adverse Drug

Reaction1 4.8%

Immunization 1 4.8%

Total 21 100%

Qualification


Registrar 10 47.6%

NA 2 9.5% Month

Total Cost

Saving ($)Senior

Registrar5 23.8% May 901024.50

Resident 2 9.5% Total 901024.50

Staff Nurse 1 4.8%

Consultant 1 4.8%

Total 21 100% DPIC QUESTIO

MAY 2012


44/87


Pediatric

Hospital11 52.4%

General

Hospital

10 47.6%

Total 21 100%

0

5

10

15

20

25

No. of Question Per

21


45/87

Reporting


Total Cost

($)

Reporting

Pharmacist

Type of

Question

Yousef Al-Omi 9 900000.00 Dina FoudaDrug

Identification

Dina Fouda 4 227.00General

information

Hajer Al-

Mudaiheem3 0.00

Adverse Drug

Reaction

Rawan Zmeili 2 343.50Immunizatio

n

Joza Al-Otaibi 2 454.00 Total

Aseera Al-Sarhan 1 0.00

Total 21 901024.50

Reporting


Yousef Al-Omi 9 43%Reporting

PharmacistType of

Question

Dina Fouda 4 19%Rawan

Zmeili

Therapeutic

Use

Hajer Al-

Mudaiheem3 14% Total

Rawan Zmeili 2 10%

Joza Al-Otaibi 2 10%

Reporting

Pharmacist

Type of

Question

Aseera Al-Sarhan 1 5%Yousef Al-

OmiPoisoning

Total 21 100% Total

TYPE OF QUESTIONER


46/87

centage

100%

0

5

10

15

20

25

Physician Nurse Pharmacist Tot

19

1 1

0

5

10

15

20

25

9

32 2

1 1 1 1 1

21

TYPE OF QUESTION


47/87


Pharmacist

Type of


Severity

Rating

1 25.0%Joza Al-

Otaibi

Dose

Standardizat

ion

2 100% 0

1 25.0% Total 2 100% 1

1 25.0% 2

1 25.0% 3a

4 100%Reporting

Pharmacist

Type of

QuestionNo. Percentage 3b

Aseera Al-

Sarhan

Pharmacoki

netic1 100% 4a

Total 1 100% 6

Total

Reporting

Pharmacist

Type of


No. PercentageHajer Al-

MudaiheemDrug

Administrati

on

1 33.3%

2 100%General

Information1 33.3%

2 100%

Dose

Standardizat

ion

1 33.3%

Total 3 100%

No. Percentage

9 100%

9 100%


48/87

al

21


49/87

No. Percentage

6 27.3%

1 4.5%

1 4.5%

1 4.5%

1 4.5%

3 13.6%

9 40.9%

22 100%


50/87



June 24 100% Poisoning 10 40.0%

Total 24 100%Drug


Drug

Availability/For

mulary

3 12.0%

Type of


Dose


Physician 16 66.7%Drug

Administration

2 8.0%

Nurse 3 12.5% Pharmacokinetic 1 4.0%

Other 1 4.2% Immunization 1 4.0%

Clinical

Pharmacist1 4.2%

Drug-Drug

Interaction1 4.0%

GS 1 4.2% Total 25 100%

Nephrologist 1 4.2%

Oncologyst 1 4.2%

Total 24 100%

Qualification

of QuestionerNo. Percentage Month

Total Cost

Saving ($)

Registrar 13 54.2% June 1000377.50

SeniorRegistrar

4 16.7% Total 1000377.50

Staff Nurse 3 12.5%

Consultant 3 12.5%

Other 1 4.2%

Total 24 100%

24

DPIC QUESTION

JUNE 2012


51/87


General

Hospital18 75.0%

Pediatric

Hospital

5 20.8%

Outside of

Hospital1 4.2%

Total 24 100%

0

5

10

15

20

25

No. of Question Per

0

10

20

30

10

53 2 2

TYPE OF QUESTI


52/87

Reporting


Total Cost

($)

Reporting

Pharmacist

Type of

Question

Dr.Yousef Al-Omi 10 1000000.00 Dina FoudaDrug

Identification

Dina Fouda 8 0.00Drug

Administratio

n

Khaja Moinuddin 3 377.50Drug-Drug

Interaction

Joza Al-Otaibi 3 0.00Immunizatio

n

Total 24 1000377.50Pharmacokin

etic

Total

Reporting


Yousef Al-Omi 10 41.7%Reporting

Pharmacist

Type of

Question

Dina Fouda 8 33.3%Khaja

MoinuddinDrug

Availability/F

ormulary


Drug

Administratio

n

Joza Al-Otaibi 3 12.5% Total

Total 24 88%

30

16

TYPE OF QUESTIONER


53/87

centage

100%

1 1 1

25

ON

0

10

31 1 1 1 1


54/87


Pharmacist

Type of


Severity

Rating

4 50.0%Joza Al-

Otaibi

Dose

Standardizat

ion

2 66.7% 6

1 12.5%Drug

Identificatio

n

1 33.3% 1

1 12.5% Total 3 100% 0

1 12.5% 2

1 13%Reporting

Pharmacist

Type of

Question

No. Percentage 3b

8 100%Yousef Al-

OmiPoisoning 10 100% Total

Total 10 100%

No. Percentage

3 75%

1 25%

4 100%

24


55/87


56/87

No. Percentage

10 40.0%

6 24.0%

5 20.0%

3 12.0%

1 4.0%

25 100%


57/87



July 10 100%Adverse Drug

Reaction3 30%

Total 10 100% GeneralInformation

3 30%

Drug

Administration2 20%

Type of


Dose

Standardization1 10%

Nurse 5 50%

Drug

Availability/For

mulary

1 10%

Physician 3 30% Total 10 100%

Dentist 2 20%

Total 10 100%

Qualification


Total Cost

Saving ($)

Staff Nurse 5 50% July 3233.00

Registrar 4 40% Total 3233.00

Senior

Registrar1 10%

Total 10 100%

DPIC QUESTION


58/87


General

Hospital10 100%

Total 10 100%

0

2

4

6

8

10

No. of Question Perc

10

JULY 2012

0

2

4

6

8

10

3 3

2

130% 30% 20% 10%

TYPE OF QUEST


59/87

Reporting


Total Cost

($)

Reporting

Pharmacist

Type of

Question

Aseera Al-Sarhan 1 0.00 Dina Fouda

Dose

Standardizati

on

Dina Fouda 1 0.00 Total

Khaja Moinuddin 6 3073.50

Joza Al-Otaibi 2 159.50

Total 10 3233.00

ReportingPharmacist


Khaja Moinuddin 6 60%Reporting

Pharmacist

Type of

Question

Joza Al-Otaibi 2 20%Aseera Al-

Sarhan

Drug

Administratio

n

Aseera Al-Sarhan 1 10% Total

Dina Fouda 1 10%

Total 10 100%


60/87

entage

100%

0

2

4

6

8

10

Nurse Physician Dentist Total

5

3

2

10

50% 30% 20%

100%

10

10%100%

ION

No.

Percentage


61/87


Pharmacist

Type of


Severity

Rating

1 100%Joza Al-

Otaibi

Adverse

Drug

Reaction

2 100% 0

1 100% Total 2 100% 1

2

3a

Reporting

Pharmacist

Type of

QuestionNo. Percentage 4b

Khaja

Moinuddin

General

Information3 50.0% 4d

Adverse

Drug

Reaction

1 16.7% Total

Drug

Administrati

on

1 16.7%

Drug

Availability/Formulary

1 16.7%

No. Percentage Total 6 100%

1 100%

1 100%


62/87

No.

Percentage


63/87

No. Percentage

3 27.3%

3 27.3%

2 18.2%

1 9.1%

1 9.1%

1 9.1%

11 100%


64/87



September 6 100%Drug

Identification3 50%

Total 6 100%Adverse Drug

Reaction1 16.7%

Drug Dilution 1 16.7%Type of


Drug in

Pregnancy1 16.7%

Physician 3 50% Total 6 100%

Nurse 1 16.7%

Clinical

Pharmacist1 16.7%

Patient 1 16.7%

Total 6 100%

Qualification


Total Cost

Saving ($)

Registrar 2 33.3% October 159.50

Senior

Registrar2 33.3% Total 159.50

Staff Nurse 1 16.7%

Patient 1 16.7%

Total 6 100%


KSMC 24 92%

KSMC/ICU 1 4%

DPIC 1 4%

Total 26 100%

0

1

2

3

4

5

6

6

DPIC QUESTIO

SEPTEMBER 201


65/87

No. of Question Pe

0

1

2

3

4

5

6

Drug

Identification

Adverse Drug

Reaction

Drug Dilution

3

1 1

50%16.7% 16.7%

TYPE OF QUESTI


66/87

Reporting


Total Cost

($)

Reporting

Pharmacist

Type of

Question

Dina Fouda 5 159.50Fatima Al-

DoliganDrug Dilution

Fatima Al-Doligan 1 0.00 Total

Total 6 159.50Reporting

Pharmacist

Type of

Question

Dina FoudaDrug

Identification

Adverse Drug

Reaction

Drug in

Pregnancy

Total

Reporting


Dina Fouda 5 83.3%

Fatima Al-Doligan 1 16.7%

Total 6 100%

100%

0

1

2

3

4

5

6

Physician Nurse Clinical Patient

3

1 1 1

50%16.7% 16.7% 16.7%

TYPE OF QUESTIONER


67/87

rcentage

Drug in

Pregnancy

Total

1

6

16.7%

100%

N


68/87

No. PercentageSeverity


1 100% 0 3 50.0%

1 100% 1 1 16.7%

2 1 16.7%

No. Percentage 3a 1 16.7%

3 60% Total 6 100%

1 20%

1 20%

5 100%

Total

6

100%


69/87


70/87



August 1 100%Drug

Administration1 100%

Total 1 100% Total 1 100%

Type of


Nurse 1 100%

Total 1 100%

Qualification


Total Cost

Saving ($)

Resident 5 19% August 184.00

Consultant 7 27%

Registrar 3 12%

Senior

Registrar

2 8% Total 184.00

Specialist 1 4%

NA 8 31%

Total 26 100%


General

Hospital1 100%

Total 1 100%0

0.2

0.4

0.6

0.8

1

No. of Question Pe

1

DPIC QUESTIO

AUGUST 2012


71/87

0

0.2

0.4

0.6

0.8

1

Drug Administration

1

TYPE OF QUEST


72/87

Reporting


Total Cost

($)

Reporting

Pharmacist

Type of

Question

Fatima Al-Doligan 1 184.00Fatima Al-

Doligan

Drug

Administratio

n

Total 1 184.00 Total

Reporting


Fatima Al-Doligan 1 100%

Total 1 100%

rcentage

100%

0

0.2

0.4

0.6

0.8

1

Nurse Total

1 1

TYPE OF QUESTIONER


73/87

Total

1

ION


74/87



1 100% 3b 1 100%

1 100% Total 1 100%


75/87

MonthNo. of

Question

Percentag

eType of Question No.

Percentag

e

October 26 100%Dosage

Administration1 4%

Total 26 100%Dosage/Administr

ation1 3.8%

DoseStandardization

1 3.8%

Type of

QuestionerNo.

Percentag

e

Dose


Clinical

Pharmacist1 4% Drug Availability 4 15.4%

Nurse 5 19% Drug Information 1 3.8%

Physician 20 77% Drug Interaction 1 3.8%

26 100% Drug Monitoring 1 3.8%

Drug-Drug

Interaction1 3.8%

General

Information3 11.5%

Infection Control 1 3.8%

Other 1 3.8%

Qualification

of QuestionerNo.

Percentag

eOthers 6 23.1%

NA 3 20.0% Pharmacokinetic 1 3.8%

Consultant 6 40.0% Poisoning 2 7.7%

Resident 5 33.3% 26 100.0%

Specialists 1 6.7%

15 100.0%


76/87

Type of QuestionReporting

Pharmacists

Dosage Administration Dr Khaja Moinuddin

Work

AddressNo.

Percentag

eDosage/Administration Dr Khaja Moinuddin

DPIC 1 4% Drug Availability Dr Khaja Moinuddin

KSMC 24 92.3% Drug Interaction Dr Khaja Moinuddin

KSMC/ICU 1 3.8% General Information Dr Khaja Moinuddin

26 100.0% Others Dr Amal Aqqad

Pharmacokinetic Dr Amal Aqqad

Drug-Drug Interaction Dr Dina fouda

GRAND TOTAL


77/87


RatingNo.

Percentag

e

1 7% 0 6 23.1%

1 7% 2 2 7.7%

4 27% 6 1 3.8%

1 7% 3a 1 3.8%

3 20% 4a 1 3.8%

3 20% NA 15 57.7%

1 7% 26 100.0%

1 7%

15 100%

Month Total Cost Saving ($)

October 0.00


78/87

MonthNo. of

Question

Perce

ntage

Qualification of


November 13 100% Consultant 4 30.8%

13 100% NA 8 61.5%

Others 1 7.7%

13 100.0%

Type of Questioner No.Perce

ntage

Pharmacist 2 15%

Physician 11 85%

13 100%


PharmacistsNo. Percentage

Adverse Drug

reaction

Dr Khaja

Moinuddin1 8%

Dr Susan

Asfour1 8% Type of Question

Reporting

Pharmacists

Dosage

Administration

Dr Khaja

Moinuddin1 8%

Dosage

Administration

Dr Khaja

Moinuddin

Drug Availability

Dr Khaja

Moinuddin 2 15%

Dosage/Administr

ation

Dr Khaja

Moinuddin

Others Dr Amal Aqqad 2 15% Drug AvailabilityDr Khaja

Moinuddin

Dr Aseera Al-

Sarhan1 8% Drug Interaction

Dr Khaja

Moinuddin

PharmacokineticsDr Aseera Al-

Sarhan1 8%

General

Information

Dr Khaja

Moinuddin

Dr Susan

Asfour1 8% Others

Dr Amal

Aqqad


79/87

Poisoning Dr Amal Aqqad 2 15% PharmacokineticDr Amal

Aqqad

Therapeutic useDr Khaja

Moinuddin1 8%

Drug-Drug

Interaction

Dr Dina

fouda

13 100% GRAND TOTAL


80/87


DPIC 1 8%

KSMC 10 76.9%

NA 2 15.4%

13 100.0%

No. Percentage

1 7%

1 7%

4 27%

1 7%

3 20%

3 20%


81/87

1 7%

1 7%

15 100%


82/87


PharmacistsNo. Percentage

Severity

RatingNo.

Adverse Drug

reactionDr Khaja Moinuddin 1 8% NA 1

Dr Susan Asfour 1 8%Dosage

AdministrationDr Khaja Moinuddin 1 8%

Drug Availability Dr Khaja Moinuddin 2 15%

Others Dr Amal Aqqad 2 15%

Dr Aseera Al-Sarhan 1 8%

Pharmacokinetics Dr Aseera Al-Sarhan 1 8%

Dr Susan Asfour 1 8%

Poisoning Dr Amal Aqqad 2 15%

Therapeutic use Dr Khaja Moinuddin 1 8%

13 100%


83/87


84/87

Percentag

eMonth Total Cost Saving ($)

November 0.00


85/87

MonthNo. of

QuestionPercentage

Qualification


December 16 100% Consultant 6 37.5%

16 100% NA 7 43.8%

Registrar 2 12.5%

Senior

Registrar1 6.3%

16 100.0%

Type of


NA 1 6%

Nurse 1 6%

other 1 6%

Pharmacist 1 6%

Physician 12 75.0%

16 100.0%


86/87

Work

AddressNo. Percentage Type of Question

Reporting

PharmacistsNo.

KSMC 13 81%Adverse Drug

Reaction

Susan Asfour 1

NA 1 6.3% Dosage Coverage Sara Salem 1

Pharmacy 1 6.3%Dose

StandardizationSuzan Asfour 1

T1B3 1 6.3% Rwan Zmeili 2

16 100.0%Drug

AdministrationDina Fouda 1

Drug Availability Khaja Moinuddin 1

Drug Coverage Suzan Asfour 1

Drug Identification Dina Fouda 2

Susan Asfour 1

Drug-Drug

InteractionAmal Al-Aqqad 1

Others Amal Al-Aqqad 2

Pharmacokinetic Amal Al-Aqqad 1

Poisoning Amal Al-Aqqad 1

16


87/87

PercentageSeverity

RatingNo. Percentage Month

Total Cost

Saving ($)

6% 1 3 18.8% December 0.00

6% 4a 1 6.3%

6% NA 12 75.0%

13% 16 100.0%

6%

6%

6%

13%

6%

6%

13%

6%

6%

100%

Drug Information Cost Analysis 24-6-2012

Documents

Transcript of Drug Information Cost Analysis 24-6-2012